Home › Funds › Tower Research Capital LLC (TRC) › NVO
Tower Research Capital LLC (TRC) position in NVO
NOVO-NORDISK A S · Health Care
Tower Research Capital LLC (TRC) reported holding 314,106 shares of NVO (NOVO-NORDISK A S) in its Q2 2026 13F filing — a position valued at US$15.1M, representing 0.37% of its reported portfolio and ranking #41 among its reported holdings. Tower Research Capital LLC (TRC) has disclosed NVO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tower Research Capital LLC (TRC)'s NVO position evolved
Tower Research Capital LLC (TRC) first disclosed a stake in NVO in Q3 2023 at 2,057 shares (US$187K). The position peaked in Q2 2026 at 314,106 shares, worth US$15.1M. Across 11 filings, Tower Research Capital LLC (TRC) increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 314,106 shares valued at US$15.1M — an increase of 282,092 shares quarter over quarter.. Notable position changes include a 126% increase in Q1 2024 (shares rose 11% over the following quarter), a 1545% increase in Q2 2025 (shares fell 20% over the following quarter), a 881% increase in Q2 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.06K | $187.06K | New |
| Q4 2023 | 3.96K | $409.35K | Add |
| Q1 2024 | 8.96K | $1.15M | Add |
| Q2 2024 | 17.02K | $2.43M | Add |
| Q3 2024 | 9.93K | $1.18M | Reduce |
| Q4 2024 | 12.62K | $1.09M | Add |
| Q1 2025 | 8.71K | $604.75K | Reduce |
| Q2 2025 | 143.24K | $9.89M | Add |
| Q3 2025 | 1.77K | $98.05K | Reduce |
| Q1 2026 | 32.01K | $1.18M | New |
| Q2 2026 | 314.11K | $15.06M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVO and 13F data
NVO (NOVO-NORDISK A S) is a Health Care company. 15 other funds we track also report a position in NVO — the largest reported positions include LOOMIS SAYLES & CO L P (US$891.4M), FOLKETRYGDFONDET (US$456.5M), EVERETT HARRIS & CO /CA/ (US$310.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVO
- LOOMIS SAYLES & CO L P 18.59M sh · $891.41M · Q2 2026
- FOLKETRYGDFONDET 9.52M sh · $456.50M · Q2 2026
- EVERETT HARRIS & CO /CA/ 6.48M sh · $310.44M · Q2 2026
More on Tower Research Capital LLC (TRC)
FAQ
How long has Tower Research Capital LLC (TRC) held NVO?
Tower Research Capital LLC (TRC) has disclosed NVO holdings in 11 of the last 12 reported quarters, going back to Q3 2023.
What is Tower Research Capital LLC (TRC)'s current position in NVO?
As of Q2 2026, Tower Research Capital LLC (TRC) holds 314.11K shares of NVO (NOVO-NORDISK A S), valued at $15.06M, representing 0.37% of its reported portfolio and ranking #41.
Has Tower Research Capital LLC (TRC) been buying or selling NVO?
In the latest 13F filing (Q2 2026), Tower Research Capital LLC (TRC) increased its position in NVO. The position peaked in Q2 2026 at 314.11K shares.
Which other funds hold NVO?
Other major institutional holders of NVO include LOOMIS SAYLES & CO L P, FOLKETRYGDFONDET, EVERETT HARRIS & CO /CA/, among 15 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.